Overview
Oculo-auriculo-vertebral spectrum (OAVS), also known as Goldenhar syndrome, hemifacial microsomia, or first and second branchial arch syndrome, is a congenital condition characterized by abnormal development of structures derived from the first and second pharyngeal (branchial) arches during embryonic development. It represents a spectrum of malformations that primarily affect the ears, eyes, and vertebral column, most often in an asymmetric or unilateral fashion. OAVS is considered one of the most common craniofacial birth defects after cleft lip and palate. The hallmark features include facial asymmetry with underdevelopment of one side of the face (hemifacial microsomia), ear abnormalities ranging from small skin tags (preauricular tags) to microtia or anotia, hearing loss (conductive, sensorineural, or mixed), and ocular anomalies such as epibulbar dermoids or lipodermoids. Vertebral anomalies, particularly of the cervical spine, including hemivertebrae, fused vertebrae, and scoliosis, are also commonly observed. Additional features may include cleft lip and/or palate, cardiac defects (particularly conotruncal and septal anomalies), renal malformations, and central nervous system abnormalities. The severity of the condition varies widely, even among affected members of the same family, ranging from mild ear tags with minimal facial asymmetry to severe bilateral craniofacial involvement with multiple organ system anomalies. Treatment of OAVS is multidisciplinary and tailored to the individual's specific manifestations. Management may include reconstructive craniofacial surgery (such as mandibular distraction osteogenesis or costochondral rib grafts), surgical correction of ear malformations, hearing aids or bone-anchored hearing devices, ophthalmologic interventions for epibulbar dermoids, orthodontic treatment, speech therapy, and monitoring and management of cardiac and renal anomalies. Early intervention with audiology and speech-language services is important to optimize developmental outcomes. There is no cure, and long-term follow-up with a coordinated team of specialists is recommended.
Also known as:
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Oculo-auriculo-vertebral spectrum.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Oculo-auriculo-vertebral spectrum at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Oculo-auriculo-vertebral spectrum.
Community
No community posts yet. Be the first to share your experience with Oculo-auriculo-vertebral spectrum.
Start the conversation →Latest news about Oculo-auriculo-vertebral spectrum
No recent news articles for Oculo-auriculo-vertebral spectrum.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Oculo-auriculo-vertebral spectrum
What is Oculo-auriculo-vertebral spectrum?
Oculo-auriculo-vertebral spectrum (OAVS), also known as Goldenhar syndrome, hemifacial microsomia, or first and second branchial arch syndrome, is a congenital condition characterized by abnormal development of structures derived from the first and second pharyngeal (branchial) arches during embryonic development. It represents a spectrum of malformations that primarily affect the ears, eyes, and vertebral column, most often in an asymmetric or unilateral fashion. OAVS is considered one of the most common craniofacial birth defects after cleft lip and palate. The hallmark features include fac
At what age does Oculo-auriculo-vertebral spectrum typically begin?
Typical onset of Oculo-auriculo-vertebral spectrum is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Oculo-auriculo-vertebral spectrum?
10 specialists and care centers treating Oculo-auriculo-vertebral spectrum are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.